Alembic Pharma Gets USFDA Nod for Generic Bromfenac Ophthalmic Solution
July 9, 2024 14:13
Alembic Pharmaceuticals receives USFDA approval for its generic Bromfenac ophthalmic solution, indicated for post-cataract surgery inflammation and pain treatment.